Select Clinical Trial
Protocol Number: NRG HN009
Protocol Title: Randomized phase II/III trial of radiation with high-does Cisplatin (100 mg/m²) every three weeks versus radiation with low-does weekly Cisplatin (40 mg/m²) for patients with locoregionally advanced squamous cell carcinoma of the head and neck.
Eligibility: Men or women age 18 and older with squamous cell cancer of the head and neck without distant metastasis.
Contact Information: (910) 715-2200
____________________________________________________________________________________________
Protocol Number: NRG HN005
Protocol Title: De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
Eligibility: Oropharyngeal squamous cell carcinoma, p-16 +, < or = to 10 pack year smoking, Stage I-II
Contact Information: (910) 715-2200
____________________________________________________________________________________________